In lung cancer cells, CUDC-907 initiated G2/M phase arrest through reducing the expression of cell cycle regulatory proteins as Cdc25C, CdC2, and Cyclin B1, and by elevating p21 protein level. Here, CDC25C is linked to lung carcinoma.